blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2582391

EP2582391 - ARTHRITIS TREATMENT [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.08.2019
Database last updated on 30.04.2025
FormerThe patent has been granted
Status updated on  31.08.2018
FormerGrant of patent is intended
Status updated on  23.04.2018
FormerExamination is in progress
Status updated on  07.02.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
XBiotech, Inc
1055 West Hastings Street, Suite 300
Vancouver, British Columbia V6E 2E9 / CA
[2013/17]
Inventor(s)01 / SIMARD, John
8201 East Riverside Drive
Bldg. 4, Suite 100
Austin, TX 78744 / US
 [2013/17]
Representative(s)Lee, Nicholas John, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[2018/40]
Former [2013/17]Hart, Deborah Mary, et al
Kilburn & Strode LLP
20 Red Lion Street
London
WC1R 4PJ / GB
Application number, filing date11796483.317.06.2011
[2018/40]
WO2011US40819
Priority number, dateUS20100356176P18.06.2010         Original published format: US 356176 P
[2013/17]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2011159976
Date:22.12.2011
Language:EN
[2011/51]
Type: A2 Application without search report 
No.:EP2582391
Date:24.04.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 22.12.2011 takes the place of the publication of the European patent application.
[2013/17]
Type: B1 Patent specification 
No.:EP2582391
Date:03.10.2018
Language:EN
[2018/40]
Search report(s)International search report - published on:KR19.04.2012
(Supplementary) European search report - dispatched on:EP08.10.2013
ClassificationIPC:A61K39/395, A61P19/02, A61P19/00, A61P29/00
[2013/17]
CPC:
C07K16/245 (EP,KR,US); A61K39/395 (KR); A61K9/0019 (KR);
A61K9/0048 (KR); A61P19/00 (EP); A61P19/02 (EP,KR);
A61P27/02 (EP,KR,US); A61P29/00 (EP,KR,US); A61K2039/505 (EP,KR,US);
A61K39/39533 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/17]
Extension statesBA18.01.2013
ME18.01.2013
TitleGerman:ARTHRITIS-BEHANDLUNG[2013/17]
English:ARTHRITIS TREATMENT[2013/17]
French:TRAITEMENT DE L'ARTHRITE[2013/17]
Entry into regional phase18.01.2013National basic fee paid 
18.01.2013Search fee paid 
18.01.2013Designation fee(s) paid 
18.01.2013Examination fee paid 
Examination procedure18.01.2013Examination requested  [2013/17]
28.04.2014Amendment by applicant (claims and/or description)
24.10.2014Despatch of a communication from the examining division (Time limit: M06)
09.03.2015Reply to a communication from the examining division
10.08.2015Despatch of a communication from the examining division (Time limit: M04)
17.12.2015Reply to a communication from the examining division
29.09.2016Despatch of a communication from the examining division (Time limit: M04)
06.02.2017Reply to a communication from the examining division
05.02.2018Cancellation of oral proceeding that was planned for 27.02.2018
27.02.2018Date of oral proceedings (cancelled)
24.04.2018Communication of intention to grant the patent
23.08.2018Fee for grant paid
23.08.2018Fee for publishing/printing paid
23.08.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  24.10.2014
Opposition(s)04.07.2019No opposition filed within time limit [2019/37]
Fees paidRenewal fee
27.06.2013Renewal fee patent year 03
30.06.2014Renewal fee patent year 04
29.06.2015Renewal fee patent year 05
27.06.2016Renewal fee patent year 06
27.06.2017Renewal fee patent year 07
27.06.2018Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU17.06.2011
AL03.10.2018
CY03.10.2018
EE03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
MK03.10.2018
MT03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
TR03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
LU17.06.2019
[2022/31]
Former [2021/34]HU17.06.2011
AL03.10.2018
CY03.10.2018
EE03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
MT03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
TR03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
LU17.06.2019
Former [2021/32]HU17.06.2011
AL03.10.2018
CY03.10.2018
EE03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
TR03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
LU17.06.2019
Former [2021/26]AL03.10.2018
CY03.10.2018
EE03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
TR03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
LU17.06.2019
Former [2020/27]AL03.10.2018
EE03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
TR03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
LU17.06.2019
Former [2020/17]AL03.10.2018
EE03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
TR03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
Former [2020/08]AL03.10.2018
EE03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
Former [2019/50]AL03.10.2018
EE03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
Former [2019/40]AL03.10.2018
EE03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SK03.10.2018
SM03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
Former [2019/37]AL03.10.2018
EE03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SM03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
Former [2019/26]AL03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
PL03.10.2018
RS03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
Former [2019/25]HR03.10.2018
LT03.10.2018
LV03.10.2018
PL03.10.2018
RS03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
Former [2019/24]HR03.10.2018
LT03.10.2018
LV03.10.2018
PL03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
Former [2019/23]HR03.10.2018
LT03.10.2018
LV03.10.2018
PL03.10.2018
BG03.01.2019
IS03.02.2019
Former [2019/22]LT03.10.2018
PL03.10.2018
BG03.01.2019
IS03.02.2019
Former [2019/21]LT03.10.2018
IS03.02.2019
Former [2019/20]LT03.10.2018
Documents cited:Search[X]WO2007120828  (NOVARTIS AG [CH], et al);
 [Y]US2009298096  (SIMARD JOHN [US]);
 [XY]WO2010030979  (XBIOTECH INC [CA], et al);
ExaminationUS2009215992
by applicantUS4634664
 US5530101
 US5585089
 US5693762
 US5932188
 WO2007120828
 US2008050310
 US2009298096
 WO2010030979
 US2012015384
 WO1990US01383
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.